Published 3 years ago

Russia's second vaccine '100% effective', watchdog tells media

Summary by Reuters

A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media. The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve thousands of participants and a placebo group

0 Articles

All

Left

Center

Right

Times of India

Russia Covid 19 Vaccine: Russia says its second Covid-19 vaccine is 100% effective; Tass

Rest of World News: MOSCOW: Russia's consumer health watchdog Rospotrebnadzor on Tuesday said Russia's second vaccine against Covid-19 is 100% effective based on the resu.

3 years ago·India

Read Full Article

Reuters

Russia's second vaccine '100% effective', watchdog tells media

MOSCOW - A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media. The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve thousands of participants and a placebo group

3 years ago·United Kingdom

Read Full Article

NDTV

Russia's Second Vaccine "100% Effective" In Early-Stage Trials: Report

3 years ago·New Delhi, India

Read Full Article

Hindustan Times

Russia says its second Covid-19 vaccine EpiVacCorona is 100% effective

Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November.

3 years ago·New Delhi, India

Read Full Article

Financial Post

Russia's second vaccine '100% effective', watchdog tells media

MOSCOW — A candidate COVID-19 vaccine known as EpiVacCorona, Russia’s second to be registered, proved “100% effective” in early-stage trials, Russian consumer…

3 years ago·Canada

Read Full Article

Arab News

Russia’s second coronavirus vaccine ‘100% effective’, watchdog tells media

MOSCOW: A candidate COVID-19 vaccine known as EpiVacCorona, Russia’s second to be registered, proved “100 percent effective” in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve thousands of participants and a placebo group as a comparison.“The effectiveness of the vaccine is ma…

3 years ago·Riyadh, Saudi Arabia

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.